October 27, 2017 Clinical Research/Diagn. Licensing, IP, and Legal Product Launch

New OCREVUS (ocrelizumab) data at ECTRIMS advance clinical understanding of underlying progression in multiple sclerosis

Basel, 27 October 2017 New OCREVUS (ocrelizumab) data at ECTRIMS advance clinical understanding of underlying progression in multiple sclerosis Data show superiority of OCREVUS compared to Rebif (interferon beta-1a) in significantly reducing disability Progression Independent of Relapse Activity (PIRA) in people with relapsing multiple sclerosis (RMS) Data demonstrates first method to automatically detect and characterise... Read more

October 27, 2017 Clinical Research/Diagn. Lab Top-10 Licensing, IP, and Legal

Release of Crossover Cath Lab System, Trinias unity edition Intervention Support with Real Time Image Processing Technology Covering Wide Range of Clinical Usage from Cardiac to Peripheral Region

Cath lab system is X-ray imaging system which is used under interventional treatment to treat patients with angina or cardiac infarct by using cathether. Intervention, which is less invasive treatment compared to surgery operation, recently attracts more attention, and more rapid development has been seen with downsizing and device qualification, reduction of contrast media, and... Read more

October 27, 2017 Clinical Research/Diagn. Lab Top-10 Licensing, IP, and Legal Microscopy

Release of Crossover Cath Lab System, Trinias unity edition Intervention Support with Real Time Image Processing Technology Covering Wide Range of Clinical Usage from Cardiac to Peripheral Region

Cath lab system is X-ray imaging system which is used under interventional treatment to treat patients with angina or cardiac infarct by using cathether. Intervention, which is less invasive treatment compared to surgery operation, recently attracts more attention, and more rapid development has been seen with downsizing and device qualification, reduction of contrast media, and... Read more

October 25, 2017 Bio/Pharma/CRO Clinical Research/Diagn. Lab Top-10 M&A, Partnerships

Shimadzu Scientific Instruments, Cure Pharmaceutical Corp and CK Sciences Form a Strategic Alliance for R&D of Pharmaceutical Cannabis Products

Columbia, MD (October 25, 2017) — Shimadzu Scientific Instruments, the leading provider of cannabis testing instruments, announces it has signed a Memorandum of Understanding (MOU) with Cure Pharmaceutical Corp and CK Sciences. This collaborative agreement will focus on researching and developing safer pharmaceutical cannabis-based products and moving these products through clinical trials using FDA guidelines.... Read more

October 25, 2017 Clinical Research/Diagn. Life Science Tools

BD Breaks Ground on $60 Million Expansion of Nebraska Manufacturing Facility

COLUMBUS, Neb., Oct. 25, 2017 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, was joined today by Gov. Pete Ricketts and other state and local leaders to break ground on a $60 million upgrade of its Columbus-East facility. The 69,000 sq. ft. expansion will transform the Columbus-East facility into... Read more

October 19, 2017 Clinical Research/Diagn. Informatics & Software Life Science Tools M&A, Partnerships

Fabric Genomics Partners to Improve Pediatric Care

October 19, 2017 06:00 AM Pacific Daylight Time ORLANDO, Fla.–(BUSINESS WIRE)–Fabric Genomics has partnered with Genomics England’s 100,000 Genomes Project, Rady Children’s Institute for Genomic Medicine (RCIGM), and The Utah Genome Project (UGP), to provide fast and accurate identification of pediatric disease-causing variants to improve the clinical care of children. Fabric Genomics’ Opal™ Clinical is the only genomic interpretation and reporting... Read more

October 19, 2017 Clinical Research/Diagn. Informatics & Software Life Science Tools M&A, Partnerships

Edico Genome And Fabric Genomics Develop Integrated Solution For Genomic Analysis With The Goal Of Improving Clinical Care

Industry Leaders Partner to Provide Streamlined Variant Data Analysis Solution ORLANDO, Fla., Oct. 19, 2017 /PRNewswire/ — Today at the American Society for Human Genetics (ASHG) Annual Meeting, Edico Genome and Fabric Genomics announced their collaboration to provide an integrated solution for secondary and tertiary analysis of next-generation sequencing data. Through this partnership, users can seamlessly utilize Edico Genome’s DRAGENTM Bio-IT platform with Fabric... Read more

October 18, 2017 Clinical Research/Diagn. Product Launch

Fluidigm to Unveil High-Parameter Tissue Imaging System

SOUTH SAN FRANCISCO, Calif., Oct. 18, 2017 (GLOBE NEWSWIRE) — Fluidigm Corporation (NASDAQ:FLDM) today announced that it will unveil a commercially available system for high-parameter tissue imaging on Tuesday, October 24, 2017, via a global livestream video. This new imaging system significantly expands the number of protein biomarkers that can be simultaneously detected from tissues and tumors as compared to... Read more